Supplements and Featured Publications

Abriendo Puertas a los Profesionales con el Multimodal Maestro2

The Only Branded Steroid Indicated for Inflammation Associated with a Range of Ocular Surface Conditions

A Reliable Treatment for Blepharitis/Meibomian Gland Dysfunction, with Increased Ocular Bioavailability

Glaucoma 360: Highlights from 2021

Glaucoma 360: Highlights from 2020
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Regeneron receives another CRL for its Eylea 8 mg
2
Topcon Healthcare seeks to advance company through acquisition and new investment
3
What if? Ophthalmology without OCT – Part 3
4
Throwback Series: From epidemic to innovation in corneal surgery
5



.png)


